From commitment
to excellence

Gebro Pharma Spain

Laboratorios Gebro Pharma, S.A., the Spanish subsidiary of the Austrian company Gebro Pharma GmbH, founded in March 2002 with headquarters in Barcelona, focuses its main activities on the development and commercialization of pain and rheumatology, and it's swiftly moving into the areas of Urology and other hospital specializations.

NOTICIAS

Gebro Pharma renueva en el Plan Profarma por tercer año consecutivo como reconocimiento a su compromiso con la I+D+i en nuestro país. Un año más el Ministerio de Economía ha publicado la resolución del último Plan Profarma (2013-2016), el cual clasifica y califica anualmente a los laboratorios farmacéuticos más destacados por su compromiso con la producción y la I+D+i en España. Una iniciativa que tiene como objetivo fomentar la competitividad del sector en nuestro país y en la que Gebro Pharma cumple […] read more

Laboratorios Gebro Pharma amplía su portfolio en dolor con el lanzamiento de Paxiflas® comprimidos bucodispersables. Laboratorios Gebro Pharma inicia el año con el lanzamiento de Paxiflas®, una combinación fija de Paracetamol/Tramadol a dosis bajas (Paracetamol 325mg / Tramadol 37,5mg), indicado para el tratamiento sintomático del dolor moderado a intenso, agudo o crónico. Gracias a los mecanismos de acción complementarios de sus dos componentes, el fármaco proporciona un inicio rápido de la acción gracias a paracetamol […] read more

Gebro Pharma launches Kentera, the first transdermal patch for the treatment of overactive bladder. Gebro Pharma has launched Kentera® in Spain, the only oxybutynin transdermal patch to treat incontinence and other symptoms in adult patients with overactive bladder. Specifically, Kentera® is indicated for the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in adult patients with an overactive bladder. As explained by the head of the Urology Service at the Hospital […] read more

Gebro Pharma joins the International Brain Tumour Day to raise awareness. The Spanish Association of People Affected by Brain Tumours (ASATE); the DACER Foundation, specialized in rehabilitation of brain damage; the Hospital Universitario Ramón y Cajal in Madrid, in collaboration with Laboratorios Gebro Pharma have held a conference this morning because of International Brain Tumour Day with the aim of informing and raising awareness of this pathology and the situation and needs […] read more

Gebro Pharma and the Spanish Urology Association join forces to work together in the field of urologic diseases. Laboratorios Gebro Pharma and the Spanish Urology Association have joined forces to work together in the field of urologic pathologies. Specifically, the goal of the agreement signed by Gebro Pharma’s General Director, Sergi Aulinas, and José Manuel Cózar, the President of the Spanish Urological Association, is to develop activities in connection with training, research and innovation in the diagnosis and […] read more